Global Biomarkers Market

Global Biomarkers Market Size, Share, Growth Analysis, By Type(Safety, Efficacy), By Application(Diagnostics, Drug discovery & development), By Disease(Cancer, Cardiovascular Diseases) - Industry Forecast 2024-2031

Report ID: SQMIG35A2509 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 92 | Figures: 76

Global Biomarkers Market Competitive Landscape

To enhance their market share, major firms are implementing tactics including new product development, merger & acquisition, and collaboration. A number of market participants, including Abbott and F. Hoffmann-La Roche Ltd., are actively working on developing new biomarker solutions. To increase access to individualized oncology biomarker testing, Thermo Fisher Scientific, Inc. introduced CE-IVD (IVDD) NGS test and analysis software in August 2022.

Biomarkers Market Top Player’s Company Profiles

  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Illumina, Inc.
  • BD (Becton, Dickinson and Company)
  • Myriad Genetics, Inc.
  • Siemens Healthineers AG
  • Danaher Corporation
  • Biomerieux SA
  • Waters Corporation
  • Abbott Laboratories
  • Sysmex Corporation
  • Bio-Techne Corporation
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Pacific Biomarkers, Inc.

Biomarkers Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Biomarkers Market size was valued at around USD 66.97 billion in 2022 and is expected to rise from USD 75.88 billion in 2023 to reach a value of USD 206.04 Billion by 2031, at a CAGR of 13.3% over the forecast period (2024–2031).

To enhance their market share, major firms are implementing tactics including new product development, merger & acquisition, and collaboration. A number of market participants, including Abbott and F. Hoffmann-La Roche Ltd., are actively working on developing new biomarker solutions. To increase access to individualized oncology biomarker testing, Thermo Fisher Scientific, Inc. introduced CE-IVD (IVDD) NGS test and analysis software in August 2022. 'F. Hoffmann-La Roche AG', 'Thermo Fisher Scientific Inc.', 'Agilent Technologies, Inc.', 'QIAGEN N.V.', 'Bio-Rad Laboratories, Inc.', 'Merck & Co., Inc.', 'PerkinElmer, Inc.', 'Illumina, Inc.', 'BD (Becton, Dickinson and Company)', 'Myriad Genetics, Inc.', 'Siemens Healthineers AG', 'Danaher Corporation', 'Biomerieux SA', 'Waters Corporation', 'Abbott Laboratories', 'Sysmex Corporation', 'Bio-Techne Corporation', 'Charles River Laboratories International, Inc.', 'Eurofins Scientific SE', 'Pacific Biomarkers, Inc.'

The demand for personalized medicine is increasing, as it allows for more targeted and effective treatments for individual patients. Biomarkers play a critical role in personalized medicine, as they can be used to identify patient-specific molecular signatures that can guide treatment decisions.

Increasing Use of Companion Diagnostics: Companion diagnostics are tests that are designed to identify biomarkers that indicate whether a patient is likely to benefit from a particular therapy or not. These tests are becoming increasingly important in drug development and personalized medicine. As a result, the market for companion diagnostics is growing rapidly, with many pharmaceutical companies partnering with diagnostic companies to develop and commercialize these tests.

North America dominated the global biomarkers business in 2022 with a revenue share of more than 44.00% due to the high illness burden, increased consumer awareness of biomarkers, encouraging government initiatives, technical breakthroughs, and improvements in healthcare infrastructure. The presence of important enterprises in this area and the numerous organic and inorganic developments they have undertaken are crucial factors projected to fuel the region's growth. For instance, Akoya Biosciences, Inc. announced in November 2022 the availability of PhenoCode signature panels for high-throughput spatial biomarker discovery.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Biomarkers Market

Report ID: SQMIG35A2363 | Region: Global | Published Date: April, 2024 | Pages: 157 | Tables: 59 | Figures: 75

Global Cardiac Assist Devices Market
Buy Now GET FREE SAMPLE
Global Biomarkers Market

Report ID: UCMIG35A2285 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Implantable Loop Recorders Market
Buy Now GET FREE SAMPLE
Global Biomarkers Market

Report ID: UCMIR35A2732 | Region: Regional | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

BRIC Diabetes Care Devices Market
Buy Now GET FREE SAMPLE
Global Biomarkers Market

Report ID: UCMIR35A2924 | Region: Regional | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

U.S. Insulin Pump Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Biomarkers Market

Product ID: SQMIG35A2509

$5,300
BUY NOW GET FREE SAMPLE